Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline
ReportsWeb.com has announced the addition of the “Global Innovation and Clinical Trial Tracking Factbook Market”, The report classifies the global Innovation and Clinical Trial Tracking Factbook Market in a precise manner to offer detailed insights about
(EMAILWIRE.COM, March 23, 2018 ) Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline
Summary
GBI Research's latest report, "Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline" is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications. This pipeline is also benchmarked against its size across each segment compared to 2015 and 2016, and an assessment of the level of first-in-class innovation is provided. In addition, a detailed contextual analysis of the key drivers of this pipeline is provided, in addition to an assessment of companies present in the pipeline and historical deal value and volume.
FREE | Request Sample Copy is Available @ http://www.reportsweb.com/inquiry&RW0001851061/sample
Innovation, particularly the development of new products, is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth and ensure long-term revenue generation. Without successful innovation, which can be broadly defined as the market launch of novel therapeutic molecules that cost-effectively treat or cure diseases, the industry would face a substantial long-term decline in revenue.
A particular focus of this report is placed on analysis of the development of innovative drugs, specifically first-in-class innovation. Over recent decades, in addition to an increase in the yearly number of new chemical entity approvals by the FDA, the number and proportion of these approvals that were first-in-class at the time of approval have also increased. The proportion of first-in-class approvals has increased steadily each year since 1994, with the exception of the years 2005-2008, when the proportion was relatively high.
Browse complete Report@ http://www.reportsweb.com/Innovation-and-Clinical-Trial-Tracking-Factbook-2017-An-Assessment-of-the-Pharmaceutical-Pipeline
Reasons to buy
-Understand the current status of the field of therapeuticInnovation and Clinical Trial Tracking Factbook, and the relative clinical and commercial success of currently marketed products.
-Assess the pipeline forInnovation and Clinical Trial Tracking Factbook split by therapy area, vector type and intervention type, and stage of development. Additionally, a granular assessment of the pipeline is provided across the four major therapy areas for gene therapy: oncology, central nervous system disorders, ophthalmology, and genetic disorders.
-Gain a picture of the current competitive landscape, with a detailed breakdown of companies actively involved in the gene therapy pipeline.
-Understand the level of involvement in the landscape on the part of big pharma companies, and the extent to howInnovation and Clinical Trial Tracking Factbook fit into the overall portfolios of companies in this field.
-Understand the strategic consolidations landscape inInnovation and Clinical Trial Tracking Factbook across the past decade
Else place an Inquire before Purchase “Global Coronary Stents Market Size, Status and Forecast 2022” @ http://www.reportsweb.com/inquiry&RW0001851061/buying
(Note: If you have any special requirements, please let us know and we will offer you the report as you want.)
Contact Info:
Name: Sameer Joshi
Organization: ReportsWeb
Email: sales@reportsweb.com
Phone: +1-646-491-9876
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Summary
GBI Research's latest report, "Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline" is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications. This pipeline is also benchmarked against its size across each segment compared to 2015 and 2016, and an assessment of the level of first-in-class innovation is provided. In addition, a detailed contextual analysis of the key drivers of this pipeline is provided, in addition to an assessment of companies present in the pipeline and historical deal value and volume.
FREE | Request Sample Copy is Available @ http://www.reportsweb.com/inquiry&RW0001851061/sample
Innovation, particularly the development of new products, is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth and ensure long-term revenue generation. Without successful innovation, which can be broadly defined as the market launch of novel therapeutic molecules that cost-effectively treat or cure diseases, the industry would face a substantial long-term decline in revenue.
A particular focus of this report is placed on analysis of the development of innovative drugs, specifically first-in-class innovation. Over recent decades, in addition to an increase in the yearly number of new chemical entity approvals by the FDA, the number and proportion of these approvals that were first-in-class at the time of approval have also increased. The proportion of first-in-class approvals has increased steadily each year since 1994, with the exception of the years 2005-2008, when the proportion was relatively high.
Browse complete Report@ http://www.reportsweb.com/Innovation-and-Clinical-Trial-Tracking-Factbook-2017-An-Assessment-of-the-Pharmaceutical-Pipeline
Reasons to buy
-Understand the current status of the field of therapeuticInnovation and Clinical Trial Tracking Factbook, and the relative clinical and commercial success of currently marketed products.
-Assess the pipeline forInnovation and Clinical Trial Tracking Factbook split by therapy area, vector type and intervention type, and stage of development. Additionally, a granular assessment of the pipeline is provided across the four major therapy areas for gene therapy: oncology, central nervous system disorders, ophthalmology, and genetic disorders.
-Gain a picture of the current competitive landscape, with a detailed breakdown of companies actively involved in the gene therapy pipeline.
-Understand the level of involvement in the landscape on the part of big pharma companies, and the extent to howInnovation and Clinical Trial Tracking Factbook fit into the overall portfolios of companies in this field.
-Understand the strategic consolidations landscape inInnovation and Clinical Trial Tracking Factbook across the past decade
Else place an Inquire before Purchase “Global Coronary Stents Market Size, Status and Forecast 2022” @ http://www.reportsweb.com/inquiry&RW0001851061/buying
(Note: If you have any special requirements, please let us know and we will offer you the report as you want.)
Contact Info:
Name: Sameer Joshi
Organization: ReportsWeb
Email: sales@reportsweb.com
Phone: +1-646-491-9876
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results